News | Cardiovascular Ultrasound | January 27, 2016

Category III code meant to encourage further use of strain imaging in cardiology, cardio-oncology applications

AMA, investigational CPT code, myocardial strain imaging, cardio-oncology

January 27, 2016 — Effective Jan. 1, 2016, the American Medical Association (AMA) Current Procedural Terminology (CPT) Editorial Panel assigned a new category III CPT code, 0399T, for use in reporting myocardial strain imaging for the detection of myocardial deformation. While Category III codes generally are not initially reimbursed, they often become payable when they are used routinely in clinical practice.

Research has shown that strain imaging can improve diagnostic assessment, standardize interpretation and assist in improving the monitoring of patients over time to optimize care. Additionally, measurements derived from strain imaging have been shown to be more sensitive and less variable than gold standard measurements like EF, making it increasingly important.

American Society of Echocardiography (ASE) chamber quantification guidelines now recommend strain imaging when assessing function. ASE recommendations for assessment and monitoring with echo of cardio-oncology patients indicate strain imaging should be monitored in this patient population.

The ACVI/ASE/Industry Task Force to Standardize Deformation Imaging issued definitions to improve standardization of 2-D speckle tracking measurements.

Increasingly, studies show that assessing and monitoring strain may improve quality of patient care and reduce costs with patient readmissions.

Although strain imaging has proven to be valuable in the assessment and management of patients with echo, until now, diagnostic software solutions with strain imaging have been research-oriented, laborious and workflow-inefficient in clinical practice.

EchoInsight is among the companies pushing for increased usage of strain imaging to improve diagnostic confidence, standardization and efficiency. Epsilon Imaging’s proprietary speckle tracking technology, TissueTrack, provides robust strain imaging with automation of cardiac functional measurements. It provides clinical strain imaging for improved confidence in assessment and monitoring of wall mechanics for the entire heart. It is available as a stand-alone workstation or client-server architecture using a vendor neutral platform.

For more information: www.epsilon-imaging.com


Related Content

News | Ultrasound Women's Health

Sept. 3, 2026 — Royal Philips has introduced the eV14-2v transvaginal transducer, expanding its obstetrics and ...

Time September 04, 2026
arrow
News | Breast Imaging

Aug. 20, 2026 — Candelis, Inc. has announced a collaboration with GE HealthCare to support the distribution of Candelis ...

Time August 24, 2026
arrow
News | Clinical Trials

Aug.12, 2026 — Mendaera Inc. has announced results from a peer-reviewed study showing that its FDA-cleared Focalist ...

Time August 17, 2026
arrow
News | Radiology Business

Aug. 4, 2026 — Canon Medical Systems USA (CMSU) has appointed Tsuneo "Neo" Imai as president and chief executive officer ...

Time August 10, 2026
arrow
News | Radiology Imaging

Aug. 4, 2026 — A new study from the Harvey L. Neiman Health Policy Institute found that the time between an imaging scan ...

Time August 06, 2026
arrow
News | Point-of-Care Ultrasound (POCUS)

July 21, 2026 — Fujifilm Sonosite has launched Sonosite iLOOK, a compact ultrasound solution designed specifically for ...

Time July 22, 2026
arrow
News | Ultrasound Imaging

July 13, 2026 — Neal F. Kassell, MD, founder and chairman of the Focused Ultrasound Foundation, received the inaugural ...

Time July 13, 2026
arrow
News | Focused Ultrasound Therapy

May 7, 2026 — Openwater, an open-source medical technology company has announced a collaboration with the Sharma Lab, a ...

Time May 07, 2026
arrow
News | ASE

May 4, 2026 — The American Society of Echocardiography (ASE) has released a new guideline that provides guidance for ...

Time May 05, 2026
arrow
News | FDA

April 16, 2026 — Royal Philips has received U.S. Food and Drug Administration 510(k) clearance for the Philips Spectral ...

Time April 20, 2026
arrow
Subscribe Now